1 / 33

Continuous Positive Airway Pressure Devices

Continuous Positive Airway Pressure Devices. ALS / BLs Continuing Education Amy Gutman MD ~ EMS medical Director prehospitalmd@gmail.com. Overview. CPAP physiology Indications & contraindications EBM literature review OEMS protocol & medical director review.

Download Presentation

Continuous Positive Airway Pressure Devices

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.


Presentation Transcript

  1. Continuous Positive Airway Pressure Devices ALS / BLs Continuing Education Amy Gutman MD ~ EMS medical Director prehospitalmd@gmail.com

  2. Overview • CPAP physiology • Indications & contraindications • EBM literature review • OEMS protocol & medical director review

  3. What is CPAP (Continuous Positive Airway Pressure)? • High-flow, pressurized & concentrated O2 delivery system • Exhalation port flow restriction device provides positive end expiratory pressure (PEEP) at a set level throughout inspiration & expiration preventing upper airway structures from collapsing &“splinting” open alveoli • By placing airway under a constant level of pressure throughout the respiratory cycle, obstructions are "pushed" out of the alveoli • Increased intrathoracic pressure reduces preload & afterload, improving left ventricular function • Maintains patency of small airways & alveoli • Improves gas exchange & reduces work of breathing by moving fluid into vasculature • Improves bronchodilator delivery • Noninvasive option to support pts through a respiratory crisis, avoid ETI, or buy time until ETI can be performed in a more controlled environment

  4. CPAPvsBiPAP • CPAP • “Continuous” constant positive pressure throughout respiratory cycle • BiPAP • “Bilevels” (2) of positive pressure during different phases of the respiratory cycle • When pt breathing in, Inspiratory Positive Airway Pressure (IPAP) exerted • When pt breathing out, Expiratory Positive Airway Pressure (EPAP) exerted • “Effects of BiPAP in patients with COPD” (European Respiratory Journal; 2000 ) • BiPAP causes higher intrathoracic pressures & reduces myocardial perfusion • BiPAP causes lower tidal volumes & increases work of breathing (vs CPAP)

  5. CPAP O2 Delivery • Prehospital CPAP devices powered by O2 source delivering >50 psi • Some have a fixed flow rate, while others can be adjusted • Fixed either 35% or 100% but actual O2 concentration less depending on leaks and minute ventilation • Variable rate increases chance of inadequate oxygen supply • The percentage of oxygen delivered (FiO2) usually starts at 30% & can be increased depending on pt needs • At 28-30% FiO2 , a full tank should last approximately: • D cylinder = 28 minutes • E cylinder = 40-50 minutes • M cylinder = 4 hours

  6. Indications • Increased work of breathing limits ability to remove CO2 • Rising CO2 levels cause narcotic like brain effect (“CO2 Narcosis”) • Fatigue & high CO2 lead to further lowering of ventilation rate & respiratory failure

  7. Contraindications • Need for emergent ETI • Hypotension • Cannot follow commands • Aspiration risk • Upper GI bleed / vomiting • Recent facial trauma • Tracheostomy • Chest trauma / suspected pneumothorax • Claustrophobic (make an attempt)

  8. Side Effects • Anxiety (most common) • As CPAP increases intra-thoracic pressure & gastric distention, there is a risk of hypotension & PTX • Abruptly stopping treatment can result in decompensation & need for ETI • Give hospital advance notice

  9. COPD • Lungs lose elastic recoil from scarred alveoli & bronchioles scar • Hypercarbic (ventilation issue) • Traditional therapies involve brochodilators (requires adequate ventilation) • Difficult to ETI prehospitally without RSI • Bronchioles collapse during exhalation leading to alveolar air trapping • “Pursed lip” breathing increases “auto-PEEP” • COPD pts requiring ETI have worse outcomes than if managed conservatively

  10. Aultman Study: COPD • 55 pts in CPAP group • 3 intubations • 43 pts in no CPAP group • 15 intubations • 30% reduction in ETI

  11. Congestive Heart Failure • Incidence • 1:100 pt transports >65 yo • 25% medicare admissions • Increased interstitial fluid interferes with gas exchange / oxygenation • Lymphatics remove 10-20cc pulmonary fluid/ hr • Increased myocardial workload results in higher O2 demands in pts who often have ischemic heart disease • Traditional therapies reduce pre-load & after-load as well as remove interstitial fluid • CPAP “pushes” fluid out of alveoli back into the vascular & lymphatic tissues • 33% have ETI if no attempts at non-invasive pressure support • Intubated pts have 4 X greater mortality of non-intubated pt

  12. Aultman Study: CHF Patients • 51 pts in CPAP group • 1 Intubation • 82 pts in no CPAP group • 22 Intubations • 25% reduction in ETI

  13. Asthma • Bronchospasm & increased work of breathing • Pts cannot physically move air in & out of the lungs due to spasm • CPAP delivers aerosolized medications & “splints” open spasming alveoli & bronchioles

  14. Aultman Study: Asthma • 19 pts in CPAP group • 3 intubations • 7 pts in no CPAP group • 2 intubations • 12% reduction in ETI

  15. Equipment • Easy to use & portable • Adjustable to patient’s needs • Easily started & discontinued • Provide quantifiable & reliable airway pressures • Conservative oxygen utilization • Limited interference with administration of “traditional” cardio-respiratory therapies

  16. Necessary Components • Oxygen source capable of producing 50 psi • Tight fitting mask • Flow regulator • 30% fixed O2 concentration • When attached to an O2 cylinder, the primary regulator delivers 50 psi & device "sucks" in room air to dilute the 100% O2

  17. PEEP Valve • PEEP valve connected to exhalation port to maintain a constant circuit pressure • Each PEEP valve rated at a certain level measured in 2.5 cmH2O increments • Common increments are 5.0 or 7.5 cmH20

  18. Important Points • Continually check for air leaks & pt tolerance • Do not break seal to give meds • If pt improves, continue CPAP until ED personnel transfer pt to their equipment • If pt deteriorates, discontinue CPAP & prepare for ETI • Notify destination hospital that CPAP is been used

  19. CPAP vs. Intubation CPAP ETI • Non-invasive • Easily discontinued • Easily adjusted • BLS skill* • Minimal complications • Does not require sedation • Minimal infection risk • Comfortable and physiologic • Invasive • Requires mechanical ventilation • ALS skill • Significant complications • Requires sedation or RSI • Potential for infection • Uncomfortable and non-physiologic *Not according to MA OEMS, unfortunately

  20. Prehospital CPAP Research • Provides greatest benefit when initiated early, decreasing intubations & improving respiratory symptoms with few major complications • “Noninvasive Ventilation in Acute Cardiogenic Edema” JAMA, 2005 • Meta-analysis of 22 studies showed a 45% reduction in mortality and a 60% reduction in ETI • “Evaluation of the effect of prehospital application of CPAP therapy in acute respiratory distress”. Prehosp Disaster Med. 2010 • Prehospital CPAP beneficial for pts in acute respiratory distress • “Prehospital use of CPAP: Positive pressure = positive patient outcomes”. Emerg Med Serv, 2005 • CPAP alleviates symptoms & decreases need for ETI for pts with CHF, COPD & asthma. CPAP is a less-invasive means of providing respiratory support while meds correct underlying causes of distress • “Low-fractional oxygen concentration continuous positive airway pressure is effective in the prehospital setting” PEC, 2012 • Low FiO2 (28%-30%) CPAP effective in treatment of common prehospital respiratory emergencies

  21. Evaluation of the effect of prehospital application of CPAP therapy in acute respiratory distress. (Prehospital Disaster Med. 2010) • OBJECTIVE: • Test impact of CPAP on rural prehospital pts with acute respiratory distress • RESULTS: • During 4 months of baseline data collection, 8% pts with respiratory distress were ETI within 1st 48 hours of care with an average ICU LOS of 8 days • During 4 months of CPAP use, ETI not required for any patients in the field or in the ED, with 2 ICU admissions (average LOS 4 days) • CONCLUSIONS: • Use of prehospital CPAP beneficial in acute respiratory distress

  22. Hubble. “Estimates of cost-effectiveness of prehospital CPAP in the management of acute pulmonary edema” PEC. 2008 • METHODS • A cost-effectiveness model of implementing CPAP in an urban EMS system was derived from the societal and implementing EMS systems’ perspectives • RESULTS • Cost of consumables, equipment & training = $89 per CPAP pt • An EMS system would be expected to use CPAP 4:1000 EMS pts & expected to save 0.75 lives:1000 EMS pts at a cost of $490 per life saved • CPAP results in 1 less intubation per 6 CPAP applications reducing hospitalization costs by $4075 / year / CPAP application

  23. Aultman Study: Summary CPAP Group (n = 148) Control Group (n = 161) Key Point: 91% of all comers in the CPAP Group did not require prehospital ETI; 65% in the Control Group did require ETI to equal a 26% reduction in prehospital ETI

  24. Wisconsin EMT–Basic Study • Can EMT-Bs apply CPAP as safely as EMT-Ps? • 50 EMT-Basic services with 2 hr didactic, 2 hr lab, written & practical test • 500 applications of CPAP in 114 services • 99% met criteria for appropriate CPAP application • No field intubations required by ALS intercepts and no significant complications • All O2sats improved, dyspnea scores reduced by 50% • Results replicated in 20+ studies demonstrating that pts receiving prehospital CPAP have a significantly lower incidence of ETI compared to conventional “respiratory distress” therapy • Pts not receiving prehospital CPAP 6 x more likely to require ETI decreasing ICU admissions by 62% (Marchettaet al)

  25. Points to Consider • How good is your current therapy for respiratory distress? • Aggressive nitrates for CHF? • Aggressive use of bronchodilators? • Prehospital & ED intubation rate? • Do you have active medical oversight? • Advanced airway management is considered a sentinel event • ALS or BLS or BOTH?

  26. OEMS 3.4 Bronchospasm / Respiratory Distress Assessment & Treatment Priorities • Scene safety, BSI • Maintain open airway, assist ventilations prn, administer oxygen as needed • Check hemodynamic stability, symptoms, LOC, ABCs, vitals, monitor / ECG • Obtain OPQRST & SAMPLE • Determine level of respiratory distress • Mild: Slight wheezing. mild cough, able to move air without difficulty • Severe: Poor air movement, dyspnea, use of accessory muscles, tachypnea, tachycardia. May present without wheezes • Rapid transport w/ wo ALS. Do not allow pt to exert themselves in a position of comfort or appropriate to treatment(s) required

  27. OEMS 3.4 Bronchospasm / Respiratory Distress BLS Procedures • Activate ALS intercept but initiate rapid transport w / wo ALS • Mild Distress: • Encourage &/or assist pt to self-administer their prescribed inhaler if indicated • Continually reassess vitals • Contact Medical Control to: • Repeat a 2nd MDI dose if required & if maximum dose not reached • Assist in using MDI • Use MDI if not specifically been prescribed for patient

  28. OEMS 3.4 Bronchospasm / Respiratory Distress ALS Procedures • Mild Distress: • Albuterol 2.5-3 mg neb, with additional treatments prn • Severe Distress: • Advanced airway management prn with capnography • Albuterol 2.5-3 mg neb or MDI +/- Ipratropium 500 mcg • Additional neb treatments administered prn w / wo magnesium 2 gms IV • IV NS KVO; if SBP <100 mmHg administer 250 cc bolus or titrate to HD status • Administer CPAP if not contraindicated; nebulizer therapy can be continued with CPAP • Contact Medical Control to/for: • Repeated albuterol or ipratropium neb or MDI • Epinephrine 0.15-0.3 mg IM (may q15 min.) or 1:10,000 (NOT 1:1000), 0.1 mg- 0. 5 mg slow IVP • Magnesium Sulfate 2-4 gms IV over 5 mins • CAUTION • Use of epinephrine in pts >40 yo or with known cardiac disease or in pts who have already taken high dosage of inhalant bronchodilator medications may result in cardiac complications

  29. OEMS 3.5 CHF / Pulmonary Edema Treatment / Assessment Priorities • Scene safety & BSI • Maintain open airway, assist ventilations & administer O2 prn • Place pt in position of comfort • Determine hemodynamic stability, symptoms, LOC, ABCs, vitals, +/- monitor & ECG • OPQRST & SAMPLE history • Rapid transport w / wo ALS, do not allow pt to exert themselves & place in position of comfort

  30. OEMS 3.5 CHF / Pulmonary Edema BLS Procedures • Activate ALS intercept if necessary & available • Rapid transport, w / wo ALS • Notify receiving hospital

  31. OEMS 3.5 CHF / Pulmonary Edema ALS Procedures • Advanced airway management w/ capnography if indicated • IV NS KVO en route to the hospital • If SBP < 100 mmHg administer 250 cc bolus or titrate to HD status • NTG SL or spray if SBP > 100 mmHg; may repeat q5 mins x 2 • If pt has taken a PDE5- inhibitor (i.e. Viagra) do not administered without a medical control order • Contact Medical Control if SBP <100 mmHg • Contact Medical Control for / if: • Nitropaste 1 inch to anterior chest wall • Furosemide 20-40 mg IVP or 40-80mg IVP if patient already on diuretics • Dopamine 2 - 20 mcg/kg/min • To facilitate ETI Medical Control may order Midazolam 2.5 mg IN or slow IVP. Repeat prn to a total dose of 5 mg

  32. Summary • CPAP alleviates respiratory symptoms & decreases need for ETI for pts with respiratory distress • Safe, portable & easy to apply • Does not replace ETI, but a less-invasive means of providing respiratory support while meds work to correct the underlying cause of respiratory distress • Best results with rapid & aggressive use • Use your medical control!

  33. References • Keith Wesley MD. Wisconsin State EMS Medical Director • Mark Marchetta RN, BS, NREMT-P; Mark Resanovich, EMT-P. Aultman Health Foundation (Canton, Ohio) • OEMS website and MA State Prehospital Treatment Protocol • Brady & Mosby Textbooks “Respiratory Distress” • Also see references cited throughout presentation

More Related